SCHEMBL21546494

SCHEMBL21546494

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1ccc(-c2cccc(C#N)c2)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c1C#N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.36
BRD4 O60885 1/20 0.35
KDM4E B2RXH2 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 2/20 0.34
ADORA2A P29274 4/20 0.33
ADORA1 P30542 4/20 0.33
ADORA2B P29275 2/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ADRA2C P18825 1/20 0.33
PGR P06401 3/20 0.33
CLK4 Q9HAZ1 1/20 0.33
F11 P03951 1/20 0.32
AR P10275 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21546488 0.96 ELANE (0.36) ELANEBRD4KDM4ECYP1A2CYP3A4
SCHEMBL22761168 0.93 ELANE (0.34) ELANEBRD4KDM4ECYP1A2CYP3A4
SCHEMBL22761141 0.92 PGR (0.38) ELANEBRD4KDM4ECYP1A2CYP3A4
SCHEMBL22760710 0.91 ELANE (0.36) ELANEBRD4KDM4ECYP1A2CYP3A4
SCHEMBL21546904 0.91 ADRA2C (0.36) BRD4CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL22760695 0.90 MAP4K4 (0.38) BRD4CYP1A2CYP3A4ADORA2AADORA1
SCHEMBL21546493 0.89 ELANE (0.36) ELANEBRD4KDM4ECYP1A2CYP3A4
SCHEMBL22761078 0.88 PDE9A (0.37) ELANEKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL21546514 0.86 CHEK1 (0.38) CYP1A2CYP3A4CYP2D6ADORA2AADORA1
SCHEMBL21546511 0.86 ADRA2C (0.36) BRD4KDM4ECYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10981930-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-04-20 US disclosed
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-10 US disclosed
EP-3478793-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-11-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10981930-B2 Organic molecules for use in optoelectronic devices OR10J3, OR51E2, EPCAM ELANE 2057/4885BRD4 2909/4885KDM4E 4571/4885
US-20200385399-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OR51E2, EPCAM ELANE 2057/4885BRD4 2909/4885KDM4E 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.